Paragon Care Limited · ASX:PGC

Paragon Care — Shareholder Meeting (November 2022)

16 slides from Paragon Care's shareholder meeting presentation, Nov 23, 2022

  1. Slide 1: ASX Announcement: Annual General Meeting Presentation

    1300 369 559 info@paragoncare.com.au paragoncare.com.au ASX ANNOUNCEMENT 23 November 2022 Australian Securities Exchange Company Announcements Office ANNUAL GENERAL MEETING PRESENTATION Paragon Care Limited (ASX:PGC) (“Paragon Care”) is holding its 2022 Annual General Meeting (“AGM”) on Wednesday 23

  2. Slide 2: Annual General Meeting (AGM)

    ParagonCare COMPANY PRESENTATION 23 NOVEMBER 2022 Annual General Meeting (AGM) Paragon Care Limited ASX: PGC

  3. Slide 3: Paragon Care Ltd ASX:PGC | Copyright © 2022

    Paragon Care Ltd ASX:PGC | Copyright © 2022

  4. Slide 4: Overview

    Overview Shane Tanner Chairman

  5. Slide 5: Paragon Care Ltd ASX:PGC | Copyright © 2022

    • • • • • Paragon Care Ltd ASX:PGC | Copyright © 2022

  6. Slide 6: Paragon Care Ltd ASX:PGC | Copyright © 2022

    • • • • • • • • • • • • • • Paragon Care Ltd ASX:PGC | Copyright © 2022

  7. Slide 7: Refining the strategy / improving execution

    • An attractive set of healthcare businesses which now have a strong foundation for growth over the Strong foundation next 3-5 years for growth • Year to date business performance for FY23 is in line with expectations Building a • Our ambition is to build a $100m EBITDA business over that timeframe

  8. Slide 8: Mainly driven by the inclusion of Quantum sales for five months

    Mainly driven by the Mainly driven by the inclusion inclusion of Quantum of Quantum results for five sales for five months months This brings the full year This has also allowed PGC to fund dividend for FY22 to 1.2 cents the SMS acquisition while per share (fully franked) maintaining similar debt le

  9. Slide 9: Quantum merger and Asia strategy

    • Merger completed in February 2022 and the business continues to perform in line with expectations • The original Quantum business had operations across Australia and Asia with a focus on sales and support for higher end diagnostic imaging equipment • The Australian business has now been absorbed w

  10. Slide 10: Strategy and Growth

    Strategy and Growth Mark Hooper Group CEO and Managing Director ParagonCare

  11. Slide 11: Your partner in healthcare delivery

    “Your partner in healthcare delivery” • • • • Paragon Care Ltd ASX:PGC | Copyright © 2022

  12. Slide 12: Strategy work by pillar, project visibility and bank refinancing

    • This work is now largely complete Strategy work • Will be reviewed and approved by the Board in late 2022 by pillar • Provides a more actionable growth plan for FY24 and beyond • Group Project Management Office (PMO) function now in place Project visibility and • Provides more structure and suppor

  13. Slide 13: ParagonCare

    ParagonCare

  14. Slide 14: Devices, Diagnostics, Capital & Consumables pillars

    Pro forma Targeted revenue EBITDA • Gradual improvement in elective surgery although still variable across states / months per annum margins • Demand for pain management devices being impacted more than expected by price list reform Devices c. $90m 10%-15% • Hospital nursing capacity in rebuilding p

  15. Slide 15: Clarity around strategy and earnings outlook

    • The “light on the hill” provides clear context for PGC activities over the next 3-5 years Clarity around strategy • The current focus for the pillars is their own strategic plan which then supports a more and improved actionable growth path beyond FY23 execution • A further update will be provided

  16. Slide 16: Thank You

    Thank You

Paragon Care — Shareholder Meeting (November 2022) on 6ix